Issue 1/2021
Content (21 Articles)
Potential late effects of SARS-CoV-2 (COVID-19) infection: parallels to cancer late effects
Richard P. Phipps, Patricia J. Sime, Connor R. Phipps
Anti-cancer strategies targeting the autotaxin-lysophosphatidic acid receptor axis: is there a path forward?
Gábor Tigyi, Mélanie A. Dacheux, Kuan-Hung Lin, Junming Yue, Derek Norman, Zoltán Benyó, Sue Chin Lee
Current methods in translational cancer research
Michael W. Lee, Mihailo Miljanic, Todd Triplett, Craig Ramirez, Kyaw L. Aung, S. Gail Eckhardt, Anna Capasso
Interaction between adipose tissue and cancer cells: role for cancer progression
Jean-François Dumas, Lucie Brisson
Beyond tradition and convention: benefits of non-traditional model organisms in cancer research
Rebecca M. Harman, Sanjna P. Das, Arianna P. Bartlett, Gat Rauner, Leanne R. Donahue, Gerlinde R. Van de Walle
Visualizing cancer extravasation: from mechanistic studies to drug development
Xiao Cheng, Ke Cheng
Targeting the cytoskeleton against metastatic dissemination
Carmen Ruggiero, Enzo Lalli
Epigenetic modulation of immunotherapy and implications in head and neck cancer
Liye Zhou, Na Xu, Hirofumi Shibata, Vassiliki Saloura, Ravindra Uppaluri
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
Christin Riess, Nina Irmscher, Inken Salewski, Daniel Strüder, Carl-Friedrich Classen, Christina Große-Thie, Christian Junghanss, Claudia Maletzki
Neuroblastoma and the epigenome
Irfete S. Fetahu, Sabine Taschner-Mandl
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
Karlijn van Loon, Elisabeth J. M. Huijbers, Arjan W. Griffioen
Cohesive cancer invasion of the biophysical barrier of smooth muscle
William L. Harryman, Kendra D. Marr, Daniel Hernandez-Cortes, Raymond B. Nagle, Joe G. N. Garcia, Anne E. Cress
Neutrophil-derived granule cargoes: paving the way for tumor growth and progression
Kavita Rawat, Saima Syeda, Anju Shrivastava
An overview of genetic mutations and epigenetic signatures in the course of pancreatic cancer progression
Aamir Ali Khan, Xinhui Liu, Xinlong Yan, Muhammad Tahir, Sakhawat Ali, Hua Huang
Macrophages in multiple myeloma: key roles and therapeutic strategies
Khatora S. Opperman, Kate Vandyke, Peter J. Psaltis, Jacqueline E. Noll, Andrew C. W. Zannettino
Potential mechanisms of tumor progression associated with postoperative infectious complications
Hironori Tsujimoto, Minako Kobayashi, Hidekazu Sugasawa, Satoshi Ono, Yoji Kishi, Hideki Ueno
Galectin-3: an immune checkpoint target for musculoskeletal tumor patients
Kosei Nakajima, Vitaly Balan, Avraham Raz
The role of caspase-8 in the tumor microenvironment of ovarian cancer
Izabela Kostova, Ranadip Mandal, Sven Becker, Klaus Strebhardt
Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies
Karuna Mittal, Jaspreet Kaur, Meghan Jaczko, Guanhao Wei, Michael S. Toss, Emad A. Rakha, Emiel Adrianus Maria Janssen, Håvard Søiland, Omer Kucuk, Michelle Dian Reid, Meenakshi V. Gupta, Ritu Aneja
Safety of radiosurgery concurrent with systemic therapy (chemotherapy, targeted therapy, and/or immunotherapy) in brain metastases: a systematic review
Pierre-Yves Borius, Jean Régis, Alexandre Carpentier, Michel Kalamarides, Charles Ambroise Valery, Igor Latorzeff
Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy
Bayan Al-Share, Nour Hammad, Maria Diab